These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7851093)

  • 1. Antineutrophilic cytoplasmic antibodies (ANCA) and vasculitis.
    Staud R; Williams RC
    Compr Ther; 1994; 20(11):623-7. PubMed ID: 7851093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
    Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
    Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological tests: Anti-neutrophil cytoplasmic antibody].
    Takizawa H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():624-6. PubMed ID: 16111351
    [No Abstract]   [Full Text] [Related]  

  • 4. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
    Gross WL
    Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
    Gross WL; Csernok E; Flesch BK
    J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
    Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ANCA vasculitis].
    Bernis C
    Nefrologia; 2003; 23(2):103-6. PubMed ID: 12778872
    [No Abstract]   [Full Text] [Related]  

  • 8. Diversity of antigens recognized by ANCA--is this of clinical relevance?
    Kallenberg CG
    Nephrol Dial Transplant; 1994; 9(3):228-9. PubMed ID: 8052425
    [No Abstract]   [Full Text] [Related]  

  • 9. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
    Arnold DF; Timms A; Luqmani R; Misbah SA
    J Clin Pathol; 2010 Aug; 63(8):678-80. PubMed ID: 20702467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineutrophilic cytoplasmic antibodies (ANCA) in respiratory pathology].
    Lauque D
    Rev Mal Respir; 1996 Oct; 13(5):534-6. PubMed ID: 8999485
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
    Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of autoimmune responses in systemic vasculitis.
    Lockwood CM; Ronda N
    Ann Ital Med Int; 1992; 7(4):203-8. PubMed ID: 1338488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
    Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
    Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of antineutophil cytoplasmic antibodies].
    Zak-Gołab A; Hrycek A; Holecki M; Chudek J
    Wiad Lek; 2011; 64(1):37-42. PubMed ID: 21812362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases.
    Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
    Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
    Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antineutrophil cytoplasmic antibodies in systemic vasculitis].
    Nasonov EL; Beketova TV; Baranov AA; Aleksandrova EN; Semenkova EN; Mukhin NA
    Klin Med (Mosk); 1992; 70(11-12):21-7. PubMed ID: 1294815
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens.
    Savage CO; Gaskin G; Pusey CD; Pearson JD
    Exp Nephrol; 1993; 1(3):190-5. PubMed ID: 7915959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.